Cargando…

Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review

BACKGROUND: Oral corticosteroid use increases the risk of systemic adverse effects including osteoporosis, bone fractures, diabetes, ocular disorders and respiratory infections. We sought to understand if inhaled corticosteroid (ICS) use in asthma is also associated with increased risk of systemic e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Roshni, Naqvi, Sumrah A, Griffiths, Chris, Bloom, Chloe I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Asthma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713222/ https://www.ncbi.nlm.nih.gov/pubmed/33268342 http://dx.doi.org/10.1136/bmjresp-2020-000756

Ejemplares similares

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
por: Heatley, Heath, et al.
Publicado: (2023)

Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study
por: Celis-Preciado, Carlos Andrés, et al.
Publicado: (2023)

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β(2) agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial
por: Busse, William W, et al.
Publicado: (2013)

What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective
por: Howard, Sam, et al.
Publicado: (2016)

Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
por: Woodcock, Ashley, et al.
Publicado: (2022)

Adverse effects of salmeterol in asthma: a neuronal perspective
por: Lommatzsch, M, et al.
Publicado: (2009)

Adverse childhood experiences and asthma: trajectories in a national cohort
por: Pape, Kathrine, et al.
Publicado: (2021)

At-risk children with asthma (ARC): a systematic review
por: Buelo, Audrey, et al.
Publicado: (2018)

Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2020)

Urbanisation and asthma in low-income and middle-income countries: a systematic review of the urban–rural differences in asthma prevalence
por: Rodriguez, Alejandro, et al.
Publicado: (2019)

Effectiveness, usability and acceptability of a smart inhaler programme in patients with asthma: protocol of the multicentre, pragmatic, open-label, cluster randomised controlled ACCEPTANCE trial
por: van de Hei, Susanne J, et al.
Publicado: (2022)

Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population
por: Sagara, Hironori, et al.
Publicado: (2021)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Factors associated with relapse in adult patients discharged from the emergency department following acute asthma: a systematic review
por: Hill, Jesse, et al.
Publicado: (2017)

Step 4: stick or twist? A review of asthma therapy
por: Slater, Mariel G, et al.
Publicado: (2016)

Phenotypic characteristics and asthma severity in an East African cohort of adults and adolescents with asthma: findings from the African severe asthma project
por: Kirenga, Bruce, et al.
Publicado: (2020)

Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use
por: Pilcher, Janine, et al.
Publicado: (2015)

Development of a conceptual model of childhood asthma to inform asthma prevention policies
por: Adibi, Amin, et al.
Publicado: (2021)

Sociodemographic factors associated with time to discharge for hospitalised patients with asthma and asthma exacerbation using the Ghana Health Service District Information Management System 2 (DHIMS-2) database, 2012–2017
por: Narh, Clement T, et al.
Publicado: (2021)

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
por: Heaney, Liam G, et al.
Publicado: (2010)

An enhanced care package to improve asthma management in Malawian children: a randomised controlled trial
por: Rylance, Sarah, et al.
Publicado: (2021)

Economic burden of asthma in Singapore
por: Finkelstein, Eric A, et al.
Publicado: (2021)

Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthma
por: Bauer, Rebecca N, et al.
Publicado: (2019)

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021)

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
por: Delaney, Stephen, et al.
Publicado: (2016)

Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma
por: Lee, Lulu K, et al.
Publicado: (2020)

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)
por: Tydeman, Florence, et al.
Publicado: (2023)

Chlamydia pneumoniae-induced tumour necrosis factor alpha responses are lower in children with asthma compared with non-asthma
por: Smith-Norowitz, Tamar Anne, et al.
Publicado: (2018)

Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access
por: O'Leary, Caroline, et al.
Publicado: (2022)

Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol
por: Pitrez, Paulo Marcio, et al.
Publicado: (2023)

Reslizumab as add-on therapy in patients with refractory asthma
por: Virchow, J Christian, et al.
Publicado: (2020)

Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
por: Pernigotti, Daniele, et al.
Publicado: (2021)

Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada
por: Mayers, Irvin, et al.
Publicado: (2023)

Influence of HIV status on the management of acute asthma exacerbations
por: Adrish, Muhammad, et al.
Publicado: (2019)

Relationship of Pneumocystis antibody responses to paediatric asthma severity
por: Rayens, Emily, et al.
Publicado: (2021)

Characteristics of new adult users of mepolizumab with asthma in the USA
por: Wu, Ann Chen, et al.
Publicado: (2021)

Association of sleep disorders with asthma: a meta-analysis
por: Liu, Xueqian, et al.
Publicado: (2023)

Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations—a cross-sectional study
por: Del-Río-Navarro, Blanca Estela, et al.
Publicado: (2020)

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Differentiation of quantitative CT imaging phenotypes in asthma versus COPD
por: Choi, Sanghun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mpkdg6f7gfj7bcblr566r8k02h